Harmony Biosciences Holdings, Inc.HRMYNASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher.
Left:
||||
Year-over-year operating income growth rate
Latest
35.92%
↑ 12% above average
Average (26q)
32.06%
Historical baseline
Range
High:300.08%
Low:-64.06%
Volatility
1135.9%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 35.92% |
| Q2 2025 | -14.34% |
| Q1 2025 | 0.93% |
| Q4 2024 | -9.70% |
| Q3 2024 | 188.96% |
| Q2 2024 | -58.96% |
| Q1 2024 | 29.45% |
| Q4 2023 | -37.69% |
| Q3 2023 | 37.54% |
| Q2 2023 | 16.03% |
| Q1 2023 | -15.10% |
| Q4 2022 | 300.08% |
| Q3 2022 | -64.06% |
| Q2 2022 | 20.18% |
| Q1 2022 | -3.75% |
| Q4 2021 | 35.99% |
| Q3 2021 | -9.69% |
| Q2 2021 | 60.41% |
| Q1 2021 | 87.33% |
| Q4 2020 | -25.26% |
| Q3 2020 | 42.02% |
| Q2 2020 | 176.06% |
| Q1 2020 | 71.48% |
| Q4 2019 | -13.05% |
| Q3 2019 | -54.72% |
| Q2 2019 | 69.49% |
| Q1 2019 | 0.00% |